Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognition in schizophrenia.

P D Harvey1, C R Bowie, J I Friedman

  • 1Department of Psychiatry, Box 1229, Mount Sinai School of Medicine, New York, NY 10029, USA. pdharvey@compuserve.com

Current Psychiatry Reports
|September 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus on Subdomains and Measures of Relevance to Affective and Social Cognition Research on Bipolar Disorder (CAS-BD); Outcomes and Recommendations From an International Society for Bipolar Disorders Targeting Cognition Taskforce Study.

Bipolar disorders·2026
Same author

Predictors of mental health and academic outcomes in first-year university students: Identifying prevention and early-intervention targets - CORRIGENDUM.

BJPsych open·2025
Same author

Loneliness is associated with mentalizing and emotion recognition abilities in schizophrenia, but only in a cluster of patients with social cognitive deficits.

Journal of the International Neuropsychological Society : JINS·2023
Same author

Evidence supporting the use of a brief cognitive assessment in routine clinical assessment for psychosis.

Schizophrenia (Heidelberg, Germany)·2022
Same author

Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum.

The journal of prevention of Alzheimer's disease·2020
Same author

Predictors of mental health and academic outcomes in first-year university students: Identifying prevention and early-intervention targets.

BJPsych open·2020

Cognitive dysfunction is a key feature of schizophrenia, impacting attention and frontal lobe function. Advances in assessment and neuroimaging highlight its importance in understanding schizophrenia

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Psychology

Background:

  • Cognitive dysfunction has been recognized as a core feature of schizophrenia since its initial descriptions.
  • Early observations by Kraepelin noted impairments in cognition and attention, linking them to potential frontal lobe dysfunction.
  • Conceptions of schizophrenia have evolved, with cognitive impairment regaining prominence due to technological advancements.

Purpose of the Study:

  • To review the historical and current understanding of cognitive dysfunction in schizophrenia.
  • To emphasize the significance of cognitive impairments in etiological theories and treatment strategies for schizophrenia.
  • To highlight the impact of advanced neuropsychological and neuroimaging techniques on the study of cognitive deficits in schizophrenia.

Main Methods:

Related Experiment Videos

  • Historical literature review.
  • Analysis of conceptual shifts in schizophrenia research.
  • Examination of the role of neuropsychological and neuroimaging advancements.

Main Results:

  • Cognitive dysfunction, particularly in attention and frontal lobe functions, has been a consistent observation in schizophrenia.
  • The understanding of cognitive impairment's role in schizophrenia has fluctuated but is currently central to research.
  • Sophisticated assessment tools have revitalized the focus on cognitive deficits in schizophrenia.

Conclusions:

  • Cognitive impairment is a critical domain for understanding schizophrenia's etiology.
  • Neuroimaging and neuropsychological assessments are crucial for advancing schizophrenia research.
  • Addressing cognitive dysfunction is essential for developing effective schizophrenia treatments.